The Tracking the Future of Specialty Pharmacy 2018 Report is now available to download for free at CSIgroup.net/Survey.
The annual report is a compilation of survey responses from specialty pharmacy professionals of all levels across all specialties to help discover and identify trends, opinions and predictions for the future of the special pharmacy industry.
Within the 72 page report, readers will find insights and opinions from manufacturers, health systems and traditional specialty pharmacy professionals across the nation. Some of the findings include:
- 35.7% of the respondents identified large PBM’s and health plans as continuing to drive more patients to one another and fewer in their direction
- 67.7% of respondents have access to limited distribution drugs (LDDs)
- 13.3% of respondents say their sales team is just “Average” at winning referrals
“This report is produced by specialty pharmacy professionals, for specialty pharmacy professionals,” says President and CEO of CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC. “The responses show shifts in DIR fees, payor networks and LDDs stand out as key contributors affecting the sustainable success and growth of specialty pharmacies of all sizes. The report also reveals patient care and sales challenges faced by respondents. Our hope is the data found here can be utilized throughout the many facets of our industry as a catalyst for discussion to ultimately improve the patient journey.”
*Readers are encouraged to use the findings as a resource in whatever medium deemed necessary as long as the report is cited and linked.